Cargando…
Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway
INTRODUCTION: Temozolomide (TMZ) induces intestinal mucosa injury that cannot be fully counteracted by supportive treatment. Probiotics regulate gut microbial composition and the host immune system and may alleviate this side effect. We aimed to investigate the potential and mechanism of Lactobacill...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386857/ https://www.ncbi.nlm.nih.gov/pubmed/37521036 http://dx.doi.org/10.2147/DDDT.S403087 |
_version_ | 1785081768951414784 |
---|---|
author | Li, Xiaochong Hu, Bowen Zheng, Jiachen Pan, Zhiyong Cai, Yuxiang Zhao, Mingjuan Jin, Xiaoqing Li, Zhi-Qiang |
author_facet | Li, Xiaochong Hu, Bowen Zheng, Jiachen Pan, Zhiyong Cai, Yuxiang Zhao, Mingjuan Jin, Xiaoqing Li, Zhi-Qiang |
author_sort | Li, Xiaochong |
collection | PubMed |
description | INTRODUCTION: Temozolomide (TMZ) induces intestinal mucosa injury that cannot be fully counteracted by supportive treatment. Probiotics regulate gut microbial composition and the host immune system and may alleviate this side effect. We aimed to investigate the potential and mechanism of Lactobacillus rhamnosus GG (LGG) in relieving intestinal mucosal injury induced by TMZ. METHODS: Glioblastoma mice were divided into four groups: CON (control), LGG (10(9) CFU/mL, treated for 7 days), TMZ (50 mg/kg·d, treated for 5 days), LGG+TMZ (LGG for 7 days and TMZ subsequently for 5 days). Body weight, food intake, and fecal pH were recorded. Intestinal tissue samples were collected 1 day after the end of TMZ treatment. Degree of damage to intestine, expression of IL1β, IL6, TNFα, and IL10 in jejunum were determined. Levels of tight-junction proteins (ZO1, occludin), TLR4, IKKβ, IκBα, and P65 with their phosphorylation in jejunum were measured. RESULTS: Decreases in body weight, food intake, spleen index in the TMZ group were mitigated in the LGG+TMZ group, and the degree of intestinal shortening and damage to jejunum villus were also alleviated. The expression of tight-junction proteins in the LGG+TMZ group was significantly greater than that in the TMZ group. IκBα in intestinal tissue significantly decreased in the TMZ group, phos–IKKβ and phos-P65 increased compared to the CON group, and LGG reversed such changes in IκBα and phos-P65 in the LGG+TMZ group. Intestinal inflammatory cytokines were significantly increased in the TMZ group, but lower in the LGG+TMZ group. Moreover, expression of TLR4 in LGG group was significantly lower than that in the CON group. LGG inhibited the rise of TLR4 after TMZ in the LGG+TMZ group compared to the TMZ group. CONCLUSION: LGG inhibits the activation of the TLR4–NFκB pathway and alleviates intestinal mucosal inflammation induced by TMZ, thereby protect the jejunum villi and mucosal physical barrier. |
format | Online Article Text |
id | pubmed-10386857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103868572023-07-30 Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway Li, Xiaochong Hu, Bowen Zheng, Jiachen Pan, Zhiyong Cai, Yuxiang Zhao, Mingjuan Jin, Xiaoqing Li, Zhi-Qiang Drug Des Devel Ther Original Research INTRODUCTION: Temozolomide (TMZ) induces intestinal mucosa injury that cannot be fully counteracted by supportive treatment. Probiotics regulate gut microbial composition and the host immune system and may alleviate this side effect. We aimed to investigate the potential and mechanism of Lactobacillus rhamnosus GG (LGG) in relieving intestinal mucosal injury induced by TMZ. METHODS: Glioblastoma mice were divided into four groups: CON (control), LGG (10(9) CFU/mL, treated for 7 days), TMZ (50 mg/kg·d, treated for 5 days), LGG+TMZ (LGG for 7 days and TMZ subsequently for 5 days). Body weight, food intake, and fecal pH were recorded. Intestinal tissue samples were collected 1 day after the end of TMZ treatment. Degree of damage to intestine, expression of IL1β, IL6, TNFα, and IL10 in jejunum were determined. Levels of tight-junction proteins (ZO1, occludin), TLR4, IKKβ, IκBα, and P65 with their phosphorylation in jejunum were measured. RESULTS: Decreases in body weight, food intake, spleen index in the TMZ group were mitigated in the LGG+TMZ group, and the degree of intestinal shortening and damage to jejunum villus were also alleviated. The expression of tight-junction proteins in the LGG+TMZ group was significantly greater than that in the TMZ group. IκBα in intestinal tissue significantly decreased in the TMZ group, phos–IKKβ and phos-P65 increased compared to the CON group, and LGG reversed such changes in IκBα and phos-P65 in the LGG+TMZ group. Intestinal inflammatory cytokines were significantly increased in the TMZ group, but lower in the LGG+TMZ group. Moreover, expression of TLR4 in LGG group was significantly lower than that in the CON group. LGG inhibited the rise of TLR4 after TMZ in the LGG+TMZ group compared to the TMZ group. CONCLUSION: LGG inhibits the activation of the TLR4–NFκB pathway and alleviates intestinal mucosal inflammation induced by TMZ, thereby protect the jejunum villi and mucosal physical barrier. Dove 2023-07-25 /pmc/articles/PMC10386857/ /pubmed/37521036 http://dx.doi.org/10.2147/DDDT.S403087 Text en © 2023 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Xiaochong Hu, Bowen Zheng, Jiachen Pan, Zhiyong Cai, Yuxiang Zhao, Mingjuan Jin, Xiaoqing Li, Zhi-Qiang Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway |
title | Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway |
title_full | Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway |
title_fullStr | Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway |
title_full_unstemmed | Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway |
title_short | Probiotics Alleviate Chemotherapy-Associated Intestinal Mucosal Injury via the TLR4–NFκB Signaling Pathway |
title_sort | probiotics alleviate chemotherapy-associated intestinal mucosal injury via the tlr4–nfκb signaling pathway |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386857/ https://www.ncbi.nlm.nih.gov/pubmed/37521036 http://dx.doi.org/10.2147/DDDT.S403087 |
work_keys_str_mv | AT lixiaochong probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway AT hubowen probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway AT zhengjiachen probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway AT panzhiyong probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway AT caiyuxiang probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway AT zhaomingjuan probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway AT jinxiaoqing probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway AT lizhiqiang probioticsalleviatechemotherapyassociatedintestinalmucosalinjuryviathetlr4nfkbsignalingpathway |